Market Cap 74.77M
Revenue (ttm) 17.59M
Net Income (ttm) -21.69M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -123.31%
Debt to Equity Ratio 0.00
Volume 555,700
Avg Vol 502,184
Day's Range N/A - N/A
Shares Out 46.16M
Stochastic %K 8%
Beta 0.48
Analysts Sell
Price Target $4.00

Company Profile

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed it...

Industry: Biotechnology
Sector: Healthcare
Phone: 800 620 4187
Address:
Industrious 823 Congress Ave, Suite 300, Austin, United States
Twills08
Twills08 Feb. 4 at 1:54 PM
0 · Reply
NyseDayTrader
NyseDayTrader Feb. 4 at 1:49 PM
0 · Reply
falcon_trader11
falcon_trader11 Feb. 4 at 12:53 PM
$HYFT $AMD team is showing strong interest in Mindwalk https://www.linkedin.com/posts/janice-phua_mindwalk-accelerates-ai-drug-discovery-with-activity-7424603593015619584-KUTj?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAECIEmkBGbDMZ9v7VYSwQVbltEseQEb55_8&utm_campaign=copy_link
0 · Reply
Twills08
Twills08 Feb. 4 at 12:37 PM
0 · Reply
chucky1110
chucky1110 Feb. 4 at 11:32 AM
$HYFT ChatGPT says/ "How retail shareholders can remove a CEO (legal + practical): First, check the company’s incorporation law and bylaws (often disclosed in the Form 20-F/annual report). Shareholders don’t usually “fire” a CEO directly — they remove directors who then replace management. If shareholders holding the required % (often 10–25% or lower) requisition a special meeting, they can put a resolution to remove specific directors and elect replacements. The mechanics: Organise a voting bloc, nominate replacement directors, file proper proxy materials, solicit votes. Removal typically requires a simple majority of votes cast (unless bylaws say otherwise). With majority ownership, executio is the key: clean filings, clear reasons (performance, dilution, governance), and disciplined messaging. Pressure levers: Run a withhold-vote campaign, engage proxy advisers (ISS/Glass Lewis), contact institutions, escalate via formal shareholder letters. Win the vote → board changes → CEO replaced."
0 · Reply
windswept
windswept Feb. 4 at 10:00 AM
0 · Reply
DarcyF
DarcyF Feb. 4 at 7:45 AM
0 · Reply
Stockwise14
Stockwise14 Feb. 3 at 9:22 PM
$HYFT red days are what they are. Keep adding .. nothing happens overnight. Markets shitting the bed everywhere today, we’re down 3% on extremely low volume, I’ll happily take it. When the overall sentiment is this bad in the market ( and world), you gotta wait it out and plan for Good PR. After the amount of emails recently sent about the horrible timing on Fridays afterhour PR… believe me the next one will be done at the most perfect time when we least expect it! Til then I’ll keep adding daily!
0 · Reply
WenABVEAudit
WenABVEAudit Feb. 3 at 7:57 PM
$HYFT got 400 @ 2.44 should I avg down or is this just gonna never do anything
0 · Reply
PaoloWorld
PaoloWorld Feb. 3 at 7:45 PM
0 · Reply
Latest News on HYFT
MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript

Dec 15, 2025, 1:29 PM EST - 7 weeks ago

MindWalk Holdings Corp. (HYFT) Q2 2026 Earnings Call Transcript


MindWalk Announces Share Repurchase Program

Oct 9, 2025, 7:00 AM EDT - 4 months ago

MindWalk Announces Share Repurchase Program


MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call Transcript

Sep 15, 2025, 12:58 PM EDT - 5 months ago

MindWalk Holdings Corp. (HYFT) Q1 2026 Earnings Call Transcript


ImmunoPrecise Antibodies Announces Key Leadership Changes

Feb 24, 2025, 8:01 AM EST - 1 year ago

ImmunoPrecise Antibodies Announces Key Leadership Changes


IPA Announces Resignation of Chief Financial Officer

Dec 31, 2024, 7:56 PM EST - 1 year ago

IPA Announces Resignation of Chief Financial Officer


Twills08
Twills08 Feb. 4 at 1:54 PM
0 · Reply
NyseDayTrader
NyseDayTrader Feb. 4 at 1:49 PM
0 · Reply
falcon_trader11
falcon_trader11 Feb. 4 at 12:53 PM
$HYFT $AMD team is showing strong interest in Mindwalk https://www.linkedin.com/posts/janice-phua_mindwalk-accelerates-ai-drug-discovery-with-activity-7424603593015619584-KUTj?utm_source=social_share_send&utm_medium=android_app&rcm=ACoAAECIEmkBGbDMZ9v7VYSwQVbltEseQEb55_8&utm_campaign=copy_link
0 · Reply
Twills08
Twills08 Feb. 4 at 12:37 PM
0 · Reply
chucky1110
chucky1110 Feb. 4 at 11:32 AM
$HYFT ChatGPT says/ "How retail shareholders can remove a CEO (legal + practical): First, check the company’s incorporation law and bylaws (often disclosed in the Form 20-F/annual report). Shareholders don’t usually “fire” a CEO directly — they remove directors who then replace management. If shareholders holding the required % (often 10–25% or lower) requisition a special meeting, they can put a resolution to remove specific directors and elect replacements. The mechanics: Organise a voting bloc, nominate replacement directors, file proper proxy materials, solicit votes. Removal typically requires a simple majority of votes cast (unless bylaws say otherwise). With majority ownership, executio is the key: clean filings, clear reasons (performance, dilution, governance), and disciplined messaging. Pressure levers: Run a withhold-vote campaign, engage proxy advisers (ISS/Glass Lewis), contact institutions, escalate via formal shareholder letters. Win the vote → board changes → CEO replaced."
0 · Reply
windswept
windswept Feb. 4 at 10:00 AM
0 · Reply
DarcyF
DarcyF Feb. 4 at 7:45 AM
0 · Reply
Stockwise14
Stockwise14 Feb. 3 at 9:22 PM
$HYFT red days are what they are. Keep adding .. nothing happens overnight. Markets shitting the bed everywhere today, we’re down 3% on extremely low volume, I’ll happily take it. When the overall sentiment is this bad in the market ( and world), you gotta wait it out and plan for Good PR. After the amount of emails recently sent about the horrible timing on Fridays afterhour PR… believe me the next one will be done at the most perfect time when we least expect it! Til then I’ll keep adding daily!
0 · Reply
WenABVEAudit
WenABVEAudit Feb. 3 at 7:57 PM
$HYFT got 400 @ 2.44 should I avg down or is this just gonna never do anything
0 · Reply
PaoloWorld
PaoloWorld Feb. 3 at 7:45 PM
0 · Reply
Scam_Likely
Scam_Likely Feb. 3 at 7:39 PM
$HYFT Averaged down… ride it back up and sell at $3.00 again. Rinse repeat.
2 · Reply
Homerun416
Homerun416 Feb. 3 at 7:09 PM
$HYFT selling Jenn B dart boards to make up for my losses if anyone’s interested 🤣
0 · Reply
NyseDayTrader
NyseDayTrader Feb. 3 at 6:15 PM
$HYFT I bust balls a lot, especially about bath. When I think logically, I ask, why didn't she give a simple update on the SPC structure? Its not based off a agreement of another entity. Why was she so quiet after JPM? She could have said they made introductions with big companies, if really nothing transpired just to lead on investors. All we have is silence. Is something coming?
1 · Reply
NyseDayTrader
NyseDayTrader Feb. 3 at 5:42 PM
$HYFT I'm on record stating the technology will lead Jennifer Bath and she cant screw even this up but fk me, this woman's lack of actions is worrisome
1 · Reply
NyseDayTrader
NyseDayTrader Feb. 3 at 4:46 PM
$HYFT Jennifer Bath? You’ve been CEO since 2018 and started with a $350,000 base and now you’re at $635,000 with a 400+ thousand dollar bonus and the cap went from 200 million to 72 million today. This is a woman that showcases she has academic accomplishments from Harvard business school on her LinkedIn when she realistically took a one week course. She needs to go and go quickly
0 · Reply
NyseDayTrader
NyseDayTrader Feb. 3 at 4:27 PM
$HYFT where is the buyback? you think they would support the stock? you think Jenn will be buying stock personally here at this discount level with the groundbreaking results they’ve been having
0 · Reply
Homerun416
Homerun416 Feb. 3 at 3:20 PM
$HYFT morning. How do we fire Jenn?
2 · Reply
TheDuck23
TheDuck23 Feb. 3 at 2:57 PM
$HYFT because none of you are buying back what you sold!
3 · Reply
NyseDayTrader
NyseDayTrader Feb. 3 at 2:54 PM
$HYFT The stock loses 50% from its top 3 weeks ago and nothing....
0 · Reply
NyseDayTrader
NyseDayTrader Feb. 3 at 2:53 PM
$HYFT Jennifer Bath?
0 · Reply
Twills08
Twills08 Feb. 3 at 12:59 PM
$CAPT $HYFT $ITRM $NVO $RAIN CAPT: as predicted, gold is continuing its rise after a brief retrace. In the face of a weakening dollar, cryptocurrencies’ nascent, bear market, and threats of war, this could easily be one of the largest movers of the year. Currently mid $0.50’s. If 10:1 acquisition of the Montana Tunnel mines, we are looking at $4-5. Mineral assessment is pending, and it could be released any day. This will be key in determining the price target. Acquisition is set to be completed by the end of the first quarter. NASDAQ approved an extension based upon this pending acquisition with a deadline of March 31. I suspect we will hear something very very soon. HYFT: Just hit the reload zone. The chart is primed for rebound. They released groundbreaking news on an influenza vaccine breakthrough, and I suspect that they have an investor pool building up as we speak. I am looking for $4 per share, and it’s currently at $1.60.  ITRM: Flared almost 20% yesterday on low volume. There is not much liquidity left, and I am hopeful for a PBM update, as well as some sort of shining light at the end of the tunnel for this small bio pharmaceutical based out of Ireland. They have one of the only oral penem antibiotics approved by FDA, but have been constrained by a consistent lack of capital. Big Pharma is going to have a vested interest in picking up this company as cheap as possible, but we haven’t seen much in the way of share price movement to date. It looks good for a jump back to $.60 in my opinion. Currently at low $0.30s. NVO: earnings will be released on the fourth, and I am very bullish on this one. They had a full month of their newly FDA approved oral GLP-1 to add to the tally, and with 18,000 scripts in the first week of it’s release, I suspect a price target of $70 is reasonable. Currently trading at $58.88. RAIN: Oversold. Way oversold. No liquidity. Rapid correction incoming on this small startup with a solid financial foundation. I like this one for $8-9 per share, but earnings may send it up further. I suspect big things are coming here. Above all, DD and decide for yourself. NFA, as I’m not God’s gift to anything. GLTY.
2 · Reply
TheDuck23
TheDuck23 Feb. 3 at 12:16 PM
$HYFT buying more today!
0 · Reply